Manager - Quebec/Atlantic Government Affairs, Policy and Advocacy at Eli Lilly and Company

Quebec, Quebec, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree or higher
Minimum 5-10+ years of experience in a government relations role
Passion for the difference that the life sciences industry can make
Strong examples of leading change and driving alignment across broad cross-functional teams
Real team player with the ability to interact and collaborate
Excellent written communications and the ability to write using a variety of styles
Good presentation and verbal skills
Strong strategically and operationally
Demonstrated ability to plan, organize and prioritize
Proven experience of being able to take accountability and lead on projects or tasks
Appetite to take on new challenges, ask questions, and manage multiple projects
Confident and works well under pressure
Fluent in French and English

Responsibilities

Develop and maintain trusted relationships with key Quebec government officials, elected and non-elected, across relevant government departments in all parties
Work with both government and opposition parties to educate and advance Lilly policy positions
Have a broad sphere of influence within all areas of government relevant to the Lilly business and exchange information and ideas with key contacts both formally and informally on a regular basis
Work with professional associations and business stakeholder groups on a regional basis to educate on Lilly positions and to broaden the pharmaceutical policy debate with a focus on provincial pharmacy and medical associations, boards of trade, chambers of commerce and others with influence over provincial health care and economic policy
Facilitate a productive and informative dialogue between government, Lilly and other key stakeholders to broaden the policy debate and discussion
Serve as an active member of industry association committees to advance strategic policy objectives
Develop strategic policy position(s) on assigned priority policy issues
Develop creative ways to bring value to the health care debate on sustainability and excellence in care, to enhance our reputation as a credible partner and obtain an ongoing “seat at the table” on key issues
Maintain deep, expert knowledge of national and provincial pricing and reimbursement environments
Ensure Lilly input is provided in advance of any major policy/legislative developments
Deliver submissions to appropriate legislative/standing committees based on Lilly policy positions
Work with Legal and Compliance functions to ensure results are delivered with integrity and consistent with all applicable laws

Skills

Government Relations

Policy Advocacy

Stakeholder Engagement

Public Affairs

Healthcare Policy

Relationship Building

Political Networking

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free